AASLD: Drug for Autoimmune Liver Disease Promising (CME/CE)

(MedPage Today) — SAN FRANCISCO -– An investigational drug aimed at primary biliary cirrhosis, an autoimmune liver disease, showed “clear biochemical improvement” in a short trial, a researcher said here.

Post a Comment

Comments are closed.